Want to track 9969 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InnoCare Pharma Ltd. (9969) Statistics
Valuation metrics
Market Cap 29.31B
Enterprise value 13.98B
Trailing P/E (ttm) 30.66
Forward P/E 106.5
PEG ratio 0.07
Price/Sales (ttm) 7.34
Price/Book (mrq) 2.96
Enterprise Value/Revenue 5.59
Enterprise Value/EBITDA 20.82
Overview
Shares outstanding 1.76B
Float 1.17B
Shares short -
% Held by insiders 0.2%
% Held by institutions 0.39%
Average volume (10 days) 6.92M
Average volume (90 days) 8.39M
Price summary
52-Week low 9.65
52-Week high 20.62
Beta 0.35
50-Day moving average 13.29
200-Day moving average 12.73
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2024
Profitability
Profit margin 0.29%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.1%
Income Statement
Revenue (ttm) 2.9B
Revenue per share (ttm) 1.42
Quarterly revenue growth (yoy) 0.39%
Gross profit (ttm) 2.65B
EBITDA 721.58M
Net income to common (ttm) 841.08M
Diluted EPS (ttm) 0.41
Quarterly earnings growth (yoy) 4.89%
Balance Sheet
Total cash (mrq) 8.17B
Total cash per share (mrq) 4.01
Total debt (mrq) 2.08B
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 5.65%
Book value per share (mrq) 4.16
Cash Flow
Cash flow statement 36.39M
Levered free cash flow (LFCF) 341.86M
